Skip to main content

Table 1 Patients’ and tumor characteristics

From: Hippocampus-sparing radiotherapy using volumetric modulated arc therapy (VMAT) to the primary brain tumor: the result of dosimetric study and neurocognitive function assessment

  Number   Percent
Median Age (range) 49.5 yrs. (26-77)
Sex
 Male 11   42.3
 Female 15   57.7
Diagnosis
 WHO I
  Pituitary adenoma 2 4 15.4
  Megingioma 1
  Craniopharyngioma 1
 WHO II
  Oligodendroglioma 3 8 30.8
  Atypical meningioma 3
  Diffuse astrocytoma 1
  Ependymoma 1
 WHO III
  Anaplastic astrocytoma 2 6 23.1
  Anaplastic oligodendroglioma 2
  Anaplastic meningioma 1
  Anaplastic hemangiopericytoma 1
 WHO IV
  Glioblastoma 7 8 30.8
  Gliosarcoma 1
Surgery
 GTR/STR 22   84.6
 Bx only/No surgery 4   15.4
Concurrent Chemotherapy 8   30.8
Location
 Frontal 5   19.2
 Parietal 5   19.2
 Temporal 6   23.1
 Ocippital 1   3.8
 Temporo-parietal 2   7.7
 Fronto-temporal 1   3.8
 Fronto-Prietal 1   3.8
 Central 5   19.2
Planning Target Volume (PTV)
 Vol(cc) 173.1 cm3 (30.3-493.6)
 Prescribed dose 60 Gy (40-60)
  1. GTR gross total resection; STR, subtotal resection